Commercializing biomedical research through securitization techniques, is a extremely interesting scientific article of our colleague José María Fernández.
Chema Fernández is a researcher at the MIT´s Lab Financial Engineering. He is interested in using capital markets and financial theory to help progress our economies and to address the challenges of humanity. In this article Chema with Roger Stein & Andrew Lo present the challenge of combining portfolio theory and structured finance principles to design a new financial vehicle to raise money for cancer research.
He got his MBA degree in 2010 from MIT Sloan as part of the Sloan Fellows Program in Innovation and Global Leadership. He also serves as Governor in the Board of Governors of the Sloan Fellow Society. Prior to MIT he worked as Managing Director for Credit Agricole CIB in London where he led the DCM Global Origination department for Sovereigns, Supras and Agencies. Before this he was Deputy Director General of the Spanish Treasury Department and Head of the Public debt department (Ministry of Finance, Madrid).